search
Back to results

Addressing Intimate Partner Violence, Mental Health, and HIV in Antenatal Care

Primary Purpose

Partner Abuse, Depression, Adherence, Medication

Status
Recruiting
Phase
Not Applicable
Locations
South Africa
Study Type
Interventional
Intervention
Asiphephe health worker training
Asiphephe therapeutic sessions
IPV assessment
Referral for IPV or Mental Health
Sponsored by
University of Witwatersrand, South Africa
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Partner Abuse focused on measuring intimate partner violence, perinatal depression, ART adherence, HIV, antenatal care, prevention of mother-to-child transmission

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • 18 years or older (the age of research consent in South Africa)
  • currently pregnant and less than 30 weeks gestation (from antenatal green card)
  • speak a study language (English, isiZulu, Sesotho)
  • living with HIV (self-reported and confirmed on green card)
  • report past-year IPV (score of ≥1 on WHO multicountry study instrument)
  • are willing to provide informed consent

Exclusion Criteria:

  • fail to meet all of the inclusion criteria
  • at risk of immediate danger (current suicidality, homicidality, or risk to child safety)
  • planning to terminate the pregnancy

Sites / Locations

  • Malvern ClinicRecruiting
  • Yeoville Clinic

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Intervention

Enhanced standard of care

Arm Description

The Asiphephe (meaning "Let us stay safe") intervention is a problem-solving therapy manual delivered in a one-on-one setting by lay health workers during routine antenatal care. Lay health workers are already employed by the Department of Health and are trained in-service (30 hours) and receive monthly supervision (total of approximately 6 one-on-one hours; 15 group hours). Asiphephe includes illustrated job aids, participant workbook, intervention checklist, and an intervention manual. The model is informed by problem-solving therapy (Lund, 2018), trauma-informed coping (Sikkema, 2018) and safety planning (Garcia-Moreno, forthcoming) and was piloted with 12 health workers with input from 3 global mental health experts.

The enhanced standard of care condition will entail a clinic-wide training (5 hours) on IPV, mental health, and HIV care in order to sensitize staff to the nature of the research. The clinic will receive access to established referral network to which participants can gain additional help with violence exposure or mental ill health. Participants in this arm will also be observed for adverse events and social harms, with referrals made appropriately by study staff.

Outcomes

Primary Outcome Measures

Depression
Depressive symptoms using Patient Health Questionnaire-9 will be assessed as a continuous marker of symptomology (with ≥13 indicating probable depression)
Intimate partner violence
IPV exposure will be measured using the World Health Organization multicountry study instrument of behaviorally-specific likert-type items about frequency of physical, sexual, or psychological violence from a partner. Any IPV will be defined as an affirmative response to any physical, sexual, or psychological violence question. For primary outcome assessment, the WHO instrument will be examined as a continuous measure summing all standardized response items as a marker of IPV intensity (Tsai, 2016).

Secondary Outcome Measures

ART adherence
Self-reported ART adherence will be collected using a multi-item measure (Wilson et al, 2014).

Full Information

First Posted
May 16, 2022
Last Updated
May 19, 2022
Sponsor
University of Witwatersrand, South Africa
Collaborators
University of North Carolina, Chapel Hill, National Institute of Mental Health (NIMH)
search

1. Study Identification

Unique Protocol Identification Number
NCT05389358
Brief Title
Addressing Intimate Partner Violence, Mental Health, and HIV in Antenatal Care
Official Title
Pilot Intervention for Addressing Intimate Partner Violence, Mental Health, and HIV in Antenatal Care
Study Type
Interventional

2. Study Status

Record Verification Date
May 2022
Overall Recruitment Status
Recruiting
Study Start Date
April 26, 2022 (Actual)
Primary Completion Date
March 31, 2024 (Anticipated)
Study Completion Date
June 30, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Witwatersrand, South Africa
Collaborators
University of North Carolina, Chapel Hill, National Institute of Mental Health (NIMH)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This quasi-experimental feasibility study recruit n=40 participants from each of two public antenatal clinics in Johannesburg, South Africa. Using the Bowen et al. approach, key feasibility study questions will be those around acceptability, implementation, and promising effects on intermediate variable. While this pilot trial is not powered to determine efficacy, it can help establish whether intervention targets the appropriate intermediate mechanisms (i.e. primary endpoints of IPV exposure and depressive symptoms) and moves intended outcomes in the right direction (i.e. towards better adherence as measured by self-reported adherence).
Detailed Description
Prevention of mother-to-child transmission (PMTCT) programs are effective if women take medication regularly, yet many perinatal women in sub-Saharan Africa have sup-optimal adherence. Intimate partner violence (IPV) worsens women's ability to adhere to antiretroviral therapy (ART), and leads to higher rates of depression. In a quasi-experimental feasibility study in South Africa, 2 inner-city Johannesburg clinics will be assigned to intervention or enhanced standard of care conditions. Intervention consists of training health workers to deliver one-on-one sessions in pregnancy (4 sessions) and postpartum (2 sessions) using problem-solving therapy and safety planning. Following n=80 women in a prospective cohort will allow for preliminarily assessment of intervention effects on: perinatal depression, IPV exposure, and ART adherence at 6 months postpartum. Additional qualitative research with 10 providers and 15 beneficiaries will help us qualitatively assess acceptability of intervention content, measures, and study conditions. This pilot trial can establish acceptability of intervention and control conditions and provide preliminary point estimates to inform future trial design.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Partner Abuse, Depression, Adherence, Medication
Keywords
intimate partner violence, perinatal depression, ART adherence, HIV, antenatal care, prevention of mother-to-child transmission

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
2 primary health clinics offering antenatal care services in inner-city Johannesburg, South Africa will be randomized to receive intervention or enhanced standard of care. Within each clinic n=40 participants will take part in baseline, midline, and endline assessments.
Masking
ParticipantOutcomes Assessor
Masking Description
Participants at routine antenatal care will not know whether their clinic is the intervention or enhanced usual care arm, since both will offer support that is over-and-above standard care. Outcomes will be assessed using self-completed tablet computers, so there is no outcomes assessor.
Allocation
Randomized
Enrollment
80 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention
Arm Type
Experimental
Arm Description
The Asiphephe (meaning "Let us stay safe") intervention is a problem-solving therapy manual delivered in a one-on-one setting by lay health workers during routine antenatal care. Lay health workers are already employed by the Department of Health and are trained in-service (30 hours) and receive monthly supervision (total of approximately 6 one-on-one hours; 15 group hours). Asiphephe includes illustrated job aids, participant workbook, intervention checklist, and an intervention manual. The model is informed by problem-solving therapy (Lund, 2018), trauma-informed coping (Sikkema, 2018) and safety planning (Garcia-Moreno, forthcoming) and was piloted with 12 health workers with input from 3 global mental health experts.
Arm Title
Enhanced standard of care
Arm Type
Active Comparator
Arm Description
The enhanced standard of care condition will entail a clinic-wide training (5 hours) on IPV, mental health, and HIV care in order to sensitize staff to the nature of the research. The clinic will receive access to established referral network to which participants can gain additional help with violence exposure or mental ill health. Participants in this arm will also be observed for adverse events and social harms, with referrals made appropriately by study staff.
Intervention Type
Behavioral
Intervention Name(s)
Asiphephe health worker training
Intervention Description
Lay health workers are already employed by the Department of Health and are trained in-service (30 hours) and receive monthly supervision (total of approximately 6 one-on-one hours; 15 group hours).
Intervention Type
Behavioral
Intervention Name(s)
Asiphephe therapeutic sessions
Intervention Description
Asiphephe sessions are manualized using illustrated job aids, a participant workbook, session checklists, and an intervention manual. The model is informed by problem-solving therapy (Lund, 2018), trauma-informed coping (Sikkema, 2018) and safety planning (Garcia-Moreno, forthcoming) and was piloted with 12 health workers with input from 3 global mental health experts.
Intervention Type
Other
Intervention Name(s)
IPV assessment
Intervention Description
IPV intensity as measured by WHO Multicountry Study Instrument at a cut-off of any past-year physical/sexual/psychological violence exposure vs. none
Intervention Type
Other
Intervention Name(s)
Referral for IPV or Mental Health
Intervention Description
Study staff are trained to recognize signs or symptoms of distress and to make appropriate referrals to appropriate community-based services, if necessary. Experienced mental health professionals on the investigative can be consulted or referred to should a participant exhibit severe symptom of mental distress.
Primary Outcome Measure Information:
Title
Depression
Description
Depressive symptoms using Patient Health Questionnaire-9 will be assessed as a continuous marker of symptomology (with ≥13 indicating probable depression)
Time Frame
6 months postpartum
Title
Intimate partner violence
Description
IPV exposure will be measured using the World Health Organization multicountry study instrument of behaviorally-specific likert-type items about frequency of physical, sexual, or psychological violence from a partner. Any IPV will be defined as an affirmative response to any physical, sexual, or psychological violence question. For primary outcome assessment, the WHO instrument will be examined as a continuous measure summing all standardized response items as a marker of IPV intensity (Tsai, 2016).
Time Frame
6 months postpartum
Secondary Outcome Measure Information:
Title
ART adherence
Description
Self-reported ART adherence will be collected using a multi-item measure (Wilson et al, 2014).
Time Frame
6 months postpartum
Other Pre-specified Outcome Measures:
Title
Viral suppression
Description
Log10 viral load (VL) will be abstracted from medical records.
Time Frame
6 months postpartum
Title
Anxiety
Description
Anxiety symptoms will measured by Generalized Anxiety Disorder scale-7 with a cut-off of 8 suggesting probable generalized anxiety.
Time Frame
6 months postpartum
Title
PTSD
Description
Post traumatic stress symptoms will be measured by the Harvard Trauma Questionnaire with symptom severity assessed as continuous scale.
Time Frame
6 months postpartum

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 18 years or older (the age of research consent in South Africa) currently pregnant and less than 30 weeks gestation (from antenatal green card) speak a study language (English, isiZulu, Sesotho) living with HIV (self-reported and confirmed on green card) report past-year IPV (score of ≥1 on WHO multicountry study instrument) are willing to provide informed consent Exclusion Criteria: fail to meet all of the inclusion criteria at risk of immediate danger (current suicidality, homicidality, or risk to child safety) planning to terminate the pregnancy
Facility Information:
Facility Name
Malvern Clinic
City
Johannesburg
State/Province
Gauteng
ZIP/Postal Code
2094
Country
South Africa
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lele van Eck, BA
Phone
+27813844179
Email
lelevaneck@gmail.com
First Name & Middle Initial & Last Name & Degree
Nataly Woollett, PhD
Email
woollettn@gmail.com
First Name & Middle Initial & Last Name & Degree
Nataly Woollett, PhD
Facility Name
Yeoville Clinic
City
Johannesburg
State/Province
Gauteng
ZIP/Postal Code
2198
Country
South Africa
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lele van Eck, BA
Email
lelevaneck@gmail.com

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
The pilot nature of this study and small sample mean we will not make IDP available to researchers outside of our investigative team.

Learn more about this trial

Addressing Intimate Partner Violence, Mental Health, and HIV in Antenatal Care

We'll reach out to this number within 24 hrs